Nash Duane

Avg. Two Year Performance

(16%) Avg. Purchase Return
(8%) Compound
15% Avg. Sale Return
7% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(1%)1%10%8%(16%)
Purchase Success Rate0 of 42 of 42 of 41 of 40 of 4
Average Sale Return< 1%(2%)(3%)(24%)15%
Sale Success Rate9 of 135 of 135 of 134 of 139 of 13
Drugs » Biotechnology

Executive Chairman, Director:

Holdings: 16.03K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 21.5K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--